This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Last fall, private equity and hedge fund investors were given a reprieve from the prospect of increased oversight of healthcare transactions when California Governor Gavin Newsom unexpectedly vetoed Assembly Bill 3129 (AB 3129). By: Husch Blackwell LLP
The Act increases regulatory reporting obligations and oversight of healthcare transactions involving private equity sponsors, healthcare real estate investment trusts (REITs) and management services organizations (MSOs). Maura Healy signed An Act Enhancing the Market Review Process (the Act). By: McGuireWoods LLP
Deal volume across the healthcare industry generally appears to have steadied despite headwinds. The general sentiment is that buyers have adapted to the current interest rates and are gritting their teeth and pressing forward—especially private equity (PE) investors who need to deploy their “dry powder.”.
As we begin 2024, we have highlighted the issues and trends that private equity (PE) investors should consider when evaluating transactions in the healthcare sector. W ith various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity.
Private equity sponsors and their healthcare portfolio companies are expected to ride the tailwind of an M&A rebound. As a result, sellers may be incentivized to explore market opportunities without requiring investors to gross-up purchase multiple premiums. By: DLA Piper
healthcare industry has weathered the storm over the past couple of years, we may be reaching calmer waters in the coming months. private equity investors has reached an all-time high, and with capital on the sideline ready to deploy, pressure to get deals done is on the rise. Although the U.S. Dry powder held by U.S.
Growing state-level oversight of M&A and other strategic transactions for healthcare provider businesses will impact growth strategies across major markets.
WindRose Health Investors has announced its acquisition of CardioOne. CardioOne, founded in 2023 and based in Houston, is a management services partner and technology platform designed for independent cardiology practices. By: McGuireWoods LLP
The investor-backed provider community may be feeling pressure and facing scrutiny from various angles in 2024, as federal and state agencies implement complex pre-closing review processes for healthcare transactions from an antitrust and oversight perspective.
State-level oversight of M&A and other strategic transactions involving healthcare is continuing to expand into new markets and impact growth strategies.
Last weekend, California Governor Gavin Newsom vetoed Assembly Bill (AB) 3129, which would have required healthcareinvestors to notify and obtain written consent from the California Attorney General (AG) before investing in certain healthcare facilities and providers. By: Wilson Sonsini Goodrich & Rosati
Over the last decade, private equity firms have acquired healthcare companies, hospitals, and clinics at an increasing rate. In fact, in those ten years, private equity firms have spent roughly $1 trillion on an estimated 8,000 healthcare deals. This trend is only expected to increase through 2024.
At McGuireWoods’ 16th annual Healthcare Finance & Growth (HCFG) Conference, panels of healthcare-focused investors and lenders provided insights about the healthcare M&A and debt markets. By: McGuireWoods LLP
The Bill, if enacted, would have imposed new notice and consent requirements for private equity investors involved in healthcare transactions. On September 28, 2024, California Governor Gavin Newsom vetoed California Assembly Bill 3129 (the Bill). By: Robinson+Cole Health Law Diagnosis
Morgan Healthcare Conference started with clear skies and overall optimism from investors. The 42nd annual J.P. But with Jamie Dimon’s prediction of a recession in 2024 on Tuesday morning, the climate shifted to an on-again, off-again rain. By: Bass, Berry & Sims PLC
Markenson, partner in the Healthcare and Corporate practices, as he talks with Pete Tedesco, managing director at Avesi Partners, about their perspectives on the healthcare services investment landscape. Pete will bring his years of experience and knowledge as a healthcareinvestor to the conversation. By: Venable LLP
Department of Health and Human Services is conducting office closures, workforce reductions and other organizational changes that will affect its operations. Disruptions to Change of Ownership approvals and other enforcement and compliance functions are possible as a result. By: Dechert LLP
From training, then funding, and post-acquisition support rn _ rn About The Guest(s): Joshua Catlett is an investor and advisor in the private healthcare sector. He is now the founder of a M&A advisory consultancy and brokerage, helping private practices in the healthcare sector prepare for sale and find buyers.
WindRose Health Investors has announced the acquisition of CardioOne. CardioOne, founded in 2022 and based in Houston, is a physician enablement company that serves independent cardiologists. By: McGuireWoods LLP
Court Square Capital Partners and WindRose Health Investors have completed a jointly controlled investment in Soleo Health, according to a news release. By: McGuireWoods LLP
On 19 September 2024, we were once again delighted to assemble hundreds of healthcare professionals, investors, and industry changemakers at The Langham in London for our annual Healthcare Private Equity (HPE) Europe conference. By: McDermott Will & Emery
WindRose Health Investors has announced its acquisition of SubjectWell. SubjectWell, founded in 2012 and based in Austin, Texas, is a patient access marketplace that connects people with health conditions to care options. By: McGuireWoods LLP
Wilson Sonsini’s inaugural Biotech Summit will address topics of critical importance to Biotech and Biopharmaceutical companies, including early and late-stage venture financing, partnering strategies, current and future AI trends in healthcare, and developments in M&A. By: Wilson Sonsini Goodrich & Rosati
Episode 12: Exploring Consolidation and Private Equity Investment in Physician Practice Management - In this episode of BRight Minds in Healthcare Delivery, host Eric Tower interviews Robert Aprill, a partner at Physician Growth Partners. Eric and Robert examine private equity (PE) investment in physician services, including various.
Hamilton Lane has acquired a significant equity interest in Cosette Pharmaceuticals from Avista Capital Partners and its co-investors, according to a news release. By: McGuireWoods LLP
The event attracted a large number of healthcare professionals, investors and dealmakers to the Shangri-La Hotel for a series of insightful panel discussions, the first of which focused on transaction trends in our industry over the past 12 months.
The billionaire investor bought $115 million worth of shares in SPDR S&P Regional Banking ETF (KRE) in the third quarter, making it his seventh biggest holding.
billion in investor funding over the last 12 months, spread over 156 deals, an increase of 81.4 This capability opens up a plethora of applications, from autonomous vehicles and personalized healthcare to dynamic financial modeling and beyond. Moreover, the healthcare sector stands to benefit enormously from Agentic AI.
District Court for the Southern District of Texas against US Anesthesia Partners (USAP), a large healthcare provider platform, and private equity firm Welsh, Carson, Anderson and Stowe (WC), which has been a principal investor in USAP for many years. 21, 2023, the Federal Trade Commission (FTC) brought a lawsuit in the U.S.
He has successfully built and exited two tech businesses and is now focused on acquiring and scaling vertical software companies in the energy and healthcare sectors. The mentorship from experienced investors. The key differentiator? The Hidden Goldmine: Vertical Software Companies Not all software companies are created equal.
Lightyear Capital will maintain its majority ownership in PracticeTek and current investor Greater Sum Ventures will continue to hold its investment. The post PE-backed healthcare software firms PracticeTek and Integrated Practice Solutions merge appeared first on PE Hub.
Now, more than ever, investors want to pick sectors and companies well placed to take advantage of changes in regulation, pricing. As the market has tightened, understanding the regulatory environment for investments has become even more important. By: McDermott Will & Emery
By Dom Walbanke on Growth Business - Your gateway to entrepreneurial success UPDATED: The UK has the most developed web of angel investor networks in Europe with 15,000 angel investors dotted around the country, according to the UK Business Angels Association (UKBAA). They’ve been generous with their cash, too.
According to Trivariate Research, investors should be overweight in healthcare and energy sectors, where companies will likely achieve their estimates better.
By Ankika Biswas and Pranav Kashyap (Reuters) -Europe’s main stock index climbed on Thursday, with healthcare and retail stocks leading the charge, while investors cheered growing prospects of interest rate cuts by major central banks and sifted through a wave of economic data globally. The pan-European STOXX 600 index closed 0.4%
When you hear the words “healthcare private equity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? In most of the world, healthcare is either government-run or a mixed public/private sector. Are there many private healthcare companies for PE firms to acquire?
If you’re planning on selling your healthcare business, you may be wondering who to sell it to and how you will accomplish this feat. This post examines five top ways to sell a healthcare business. Business brokers are experts who specialize in assisting business owners and investors to sell or buy companies.
By Sruthi Shankar (Reuters) -European shares fell to two-week lows on Tuesday, led by energy and healthcare stocks, as investors awaited a slew of major central bank decisions later in the week. The pan-European STOXX 600 index slipped 0.4% by 0924 GMT, trading at its lowest since Dec. Oil and gas stocks dropped 1.2% […]
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content